Schedule 13G ownership disclosure

VISTAGEN THERAPEUTICS INC

Security class unavailable · CUSIP: 92840H202

Event date: 2021-03-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,464,974
Percent of class
8.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-21-006482
Form type
SC 13G
Filer
ACUTA CAPITAL PARTNERS, LLC
CIK
CIK 1582844
Filed
Mar 22, 2021
Reporting period
Mar 12, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub